KNSA - Kiniksa Pharmaceuticals Ltd

KNSA - Kiniksa Pharmaceuticals Ltd

https://www.kiniksa.com

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

Recent Price Trend in Kiniksa Pharmaceuticals International, plc ( KNSA ) is Your Friend, Here's Why

Zacks Commentary • 1 week, 5 days ago • score: 0.43

Kiniksa Pharmaceuticals International, plc (KNSA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Uptrend

As of 2025-08-29 (Snapshot)

None

52W High

$35.84

52W Low

$17.82

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.20

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

714.20

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

392.90

EV/Revenue (<3 favorable)

4.44

P/S (TTM) (<3 favorable)

5.00

P/B (<3 favorable)

5.35

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.75%

Institutions (25–75% balanced)

93.01%

Shares Outstanding

43,472,900

Float

33,526,300

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

529,332,000

Gross Profit (TTM)

281,152,000

EPS (TTM)

0.05

Profit Margin (>10% good)

0.01%

Operating Margin (TTM) (higher better)

0.13%

ROE (TTM) (>15% strong)

0.01%

EPS YoY (Quarterly) (>10% good)

5.50

Revenue YoY (Quarterly) (>8% good)

0.44

Momentum

Bearish momentum

Value

1.6710

Previous

1.6406

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025